Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

Public Health, Biostatistics, Experimental Design +10

Evaluation of the antitumor activity of gemcitabine (2',2'-difluoro-2'-deoxycytidine).

Larry W. Hertel, G B Boder, Julian S. Kroin et al. · PubMed · 1990 · 683 citations

Medicine, Oncology, Pharmacology +11

Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study.

Luca Gianni, Elisabetta Munzone, Giuseppe Capri et al. · Journal of Clinical Oncology · 1995 · 559 citations

Medicine, Oncology, Pharmacology +17

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer.

Barbara Weber, Charles Vogel, Stephen E. Jones et al. · Journal of Clinical Oncology · 1995 · 193 citations

Medicine, Oncology, Pharmacology +14